Literature DB >> 15608801

Risk factors for type 2 diabetes in postmenopausal New Zealand women: a cross-sectional study.

Sally Rose1, Beverley Lawton, Anthony Dowell, Anna Fenton.   

Abstract

AIM: To describe the diabetes risk profile of 3377 postmenopausal New Zealand women.
METHODS: Participants took part in a face-to-face interview with a research nurse. Medical history, lifestyle information, height, weight, and random capillary blood glucose were recorded. Risk scores for type 2 diabetes were later calculated for each participant using a modified diabetes 'risk analysis' tool developed by the United States Diabetes Prevention Program (DPP).
RESULTS: 157 women had diagnosed diabetes (4.4%) and were not therefore included in the risk analysis. Over half of the women (1843 of 3377) were at 'high risk' for the development of type 2 diabetes when assessed using the DPP diabetes risk analysis tool; 38.6% of participants were overweight, 25.6% were obese, 32.5% were physically inactive, 16.9% had a family history of diabetes, and 6.5% had random capillary blood glucose recordings of 7.5 mmol/L or greater.
CONCLUSION: Risk factors for type 2 diabetes are prevalent in this group of postmenopausal New Zealand women. To appropriately target lifestyle modification programmes, these findings (in conjunction with recent evidence that lifestyle modification can reduce diabetes onset) highlight an urgent need to identify those women with risk factors before they develop type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15608801

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  2 in total

1.  The 'Women's Lifestyle Study', 2-year randomized controlled trial of physical activity counselling in primary health care: rationale and study design.

Authors:  Sally B Rose; Beverley A Lawton; C Raina Elley; Anthony C Dowell; Anna J Fenton
Journal:  BMC Public Health       Date:  2007-07-23       Impact factor: 3.295

2.  Exercise on prescription for women aged 40-74 recruited through primary care: two year randomised controlled trial.

Authors:  Beverley A Lawton; Sally B Rose; C Raina Elley; Anthony C Dowell; Anna Fenton; Simon A Moyes
Journal:  BMJ       Date:  2008-12-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.